Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 8 min ago
Peer-reviewedCC BYBiosensors

Wearable Biosensors for Continuous Monitoring of Chronic Kidney Disease: Materials, Biofluids, and Digital Health Integration

4 affiliations
  1. 1Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam 530031, AP, India
  2. 2Center for Bioelectronics, Old Dominion University, Norfolk, VA 23508, USA
  3. 3Accurex Biomedical Pvt. Ltd., Visakhapatnam 530031, AP, India
  4. 4Department of Electrical and Computer Engineering, Old Dominion University, Norfolk, VA 23508, USA

Abstract

Chronic kidney disease (CKD) is a progressive and irreversible disorder affecting over 850 million individuals globally and is associated with significant morbidity, mortality, and healthcare burden. Conventional diagnostic approaches rely on intermittent laboratory measurements, including serum creatinine, estimated glomerular filtration rate (eGFR), and urinary albumin, which provide limited temporal resolution and fail to capture dynamic physiological changes. Recent advances in wearable biosensing technologies offer new opportunities for continuous, non-invasive monitoring of biochemical and physiological markers relevant to renal function. This review provides a comprehensive analysis of wearable biosensors for CKD monitoring, focusing on sensing mechanisms (electrochemical, optical, and field-effect transistor), biofluid interfaces (sweat, interstitial fluid, and saliva), and materials engineering strategies enabling flexible, high-performance devices. Emphasis is placed on biofluid transport dynamics, analytical performance across sampling matrices, and system-level integration with wireless communication and digital health platforms. Key challenges limiting clinical translation, including biofouling, enzymatic instability, and variability in biofluid composition, are examined-alongside emerging solutions such as antifouling interfaces, synthetic recognition elements, and multimodal sensing architectures. Finally, regulatory pathways and the role of artificial intelligence in digital nephrology are discussed. This review highlights the potential of wearable biosensors to transform CKD management through continuous monitoring, early detection, and personalized therapeutic intervention.

Related

  1. In situ polymerized monolith tips for reproducible, format-flexible proteomic sample preparation applied to biofluids
    Kathrin Korff, Lukas T. Henneberg, Denys Oliinyk +9
    Molecular & Cellular ProteomicsPeer-reviewedCC BY 4.0Full textPhysical chemistryCrossref
  2. Continuous monitoring of blood–interstitial fluid intercompartmental molecular kinetics in freely moving animals
    Yihang Chen, Qitao Hu, Jean Won Kwak +10
    Science AdvancesPeer-reviewedCC BY-NC8 citedAnalytical chemistryOpenAlex
  3. A wearable paper-based SGR/MCC microneedle array sensor for continuous glucose monitoring
    Joseph Benjamin Holman, Talifhani Mushiana, C R Yang +5
    Microsystems & NanoengineeringPeer-reviewedCC BYFull text6 citedAnalytical chemistryOpenAlex
  4. Photocrosslinked dextran hydrogel coatings with FAD-glucose dehydrogenase for continuous glucose monitoring in complex media: Key role of methacrylation degree on bioelectrocatalytic activity and sensor stability
    Bastien Darmau, Vladyslav Mishyn, Abir Elloumi +2
    Biosensors and BioelectronicsPeer-reviewedCC BY5 citedGeneral chemistryHAL
  5. Geometry-Dependent Redistribution of Exocytotic Spike-Shape Populations Revealed by Ultrafast Disk and Nanotip Acetylcholine Biosensors
    Yuanmo Wang, Ajay Pradhan
    ChemRxivPreprintLicence not statedGeneral chemistryChemRxiv
BibTeX
@article{sivasubramanian2026wearable,
  title = {{Wearable Biosensors for Continuous Monitoring of Chronic Kidney Disease: Materials, Biofluids, and Digital Health Integration}},
  author = {Anupamaa Sivasubramanian and Shankara Narayanan and Gymama E. Slaughter},
  journal = {Biosensors},
  year = {2026},
  month = may,
  doi = {10.3390/bios16050287},
  url = {https://doi.org/10.3390/bios16050287},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Wearable Biosensors for Continuous Monitoring of Chronic Kidney Disease: Materials, Biofluids, and Digital Health Integration
AU  - Anupamaa Sivasubramanian
AU  - Shankara Narayanan
AU  - Gymama E. Slaughter
PY  - 2026
DA  - 2026/05/15
JO  - Biosensors
DO  - 10.3390/bios16050287
UR  - https://doi.org/10.3390/bios16050287
AB  - Chronic kidney disease (CKD) is a progressive and irreversible disorder affecting over 850 million individuals globally and is associated with significant morbidity, mortality, and healthcare burden. Conventional diagnostic approaches rely on intermittent laboratory measurements, including serum creatinine, estimated glomerular filtration rate (eGFR), and urinary albumin, which provide limited temporal resolution and fail to capture dynamic physiological changes. Recent advances in wearable biosensing technologies offer new opportunities for continuous, non-invasive monitoring of biochemical and physiological markers relevant to renal function. This review provides a comprehensive analysis of wearable biosensors for CKD monitoring, focusing on sensing mechanisms (electrochemical, optical, and field-effect transistor), biofluid interfaces (sweat, interstitial fluid, and saliva), and materials engineering strategies enabling flexible, high-performance devices. Emphasis is placed on biofluid transport dynamics, analytical performance across sampling matrices, and system-level integration with wireless communication and digital health platforms. Key challenges limiting clinical translation, including biofouling, enzymatic instability, and variability in biofluid composition, are examined-alongside emerging solutions such as antifouling interfaces, synthetic recognition elements, and multimodal sensing architectures. Finally, regulatory pathways and the role of artificial intelligence in digital nephrology are discussed. This review highlights the potential of wearable biosensors to transform CKD management through continuous monitoring, early detection, and personalized therapeutic intervention.
SN  - 2079-6374
ER  -